New Molecular Screening Approach for Discovery of Novel CycloOxygenase-2 Inhibitors through Multi Linear Regression Models
Archives of Advances in Biosciences,
Vol. 11 No. 2 (2020),
16 May 2020
,
Page 10-19
https://doi.org/10.22037/aab.v11i2.28610
Abstract
Background: Inflammation is basically caused with conversion of Arachidonic acid into Prostaglandin H2 by CycloOxygenase. In this study a new algorithmic procedure is applied in order to screen molecules not only with high affinity to COX-2, but also different from their ancestor compounds.
Methods: NSAIDs, COX-1 and COX-2 molecules were downloaded from Drug Bank and Protein Data Bank. Drugs were docked with both proteins by FlexX software. Top 10 molecules with lowest COX-2 interaction energies and highest differences between COX-2 and COX-1 IEs were selected for structural similarity searches in PUBCHEM and ENCANCED NCI databases. Second generation molecules were docked with proteins once again. Compounds with lower IEs than parents, were collected. Bioactivities and bioavailabilities of compounds were analyzed by PASS software and Lipinski rules. A best multi linear regression model was developed based on some physicochemical descriptors for further studies.
Results: 50 NSAIDs were selected and 2000 similar molecules gathered. Screening the molecules based on Lipinski rules, bioactivities and drug likenesses, a trustable BMLR model was developed with more than 80% accuracy including following descriptors: Log P, Log D, Molar Refractivity, Polarity Number, and Aromaticity Ratio. Finally, 6 compounds were selected as best structurally new compounds for further in vitro analysis.
Conclusions: Final molecules having high druglikeness and affinity and structurally different from their ancestors, can be used in order to develop new lead compounds with higher selectivity.
- CycloOxygenase
- Anti Inflammatory Drugs
- FlexX software
- PASS
- software
- MLR model
How to Cite
References
Dhikav V., Singh S., Anand K.S., (2002) Newer Non-steroidal Anti-inflammatory Drugs – A Review of Their Therapeutic Potential and Adverse Drug Reactions, JIACM; 3(4): 332-8
Fosslien E., (2000) Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin. Lab. Sci. 37:431-502
Zweifach B.W., Grant L., McCluskey R.T., (1974) The Inflammatory Process, Academic, New York, 3, 3, 450-461
Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE., (2008) Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.. Am J Gastroenterol.; 103(10):2465-73 328 (11): 719-25
Hooper L., Brown T.J., Elliott R.A., Payne K., Roberts C., Symmons D., (2010) The Effectiveness of Five Strategies for The Prevention of Gastrointestinal Toxicity Induced by Non-Steroidal Anti-Inflammatory Drugs: Systematic Review, BMJ 10, 1-10
Hashemi M., Borna H., Dadras O., Shafaroodi H., Akbarzade A., Hajiali S., (2011) Mechanistical Approach Through Discovery of New Generations of Anti Inflammatory Drugs, J. Proteomics. Bioinform. 4(12): 284-288
Ayati M., Ghasemi J.B., (2010) A QSPR Study of GC/MS Retention Data 85 volatile organic compounds as air pollutant materials by multivariate method, CHA4CH, 3
Lagunin A., Stepanchikov A., Filiminon D., Proikov V., (2000) PASS:Prediction of Activity Spectra for Biologically Active Substances, Bioinformatics Applications Note, 16, 8, 747-748
Dobson P.D., Patel Y., Kell D.B., (2009) ‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries, Drug Discovery Today, 14, 31-40
Latha P.P., Sharmila J.S., (2010) QSAR Study for The Prediction of IC50 and Log P for 5-N-Acetyl-Beta-Dneuraminic Acid Structurally Similar Compounds Using Stepwise (Multivariate) Linear Regression, International Journal of Chemical Research 2, Issue 1, 32-38.
Sharma B.K., Pilania P., Singh P., Prabhakar Y.S., (2011) A QSAR study on 2-(4-Methylpiperazin-1-yl)quinoxalines as human histamine H4 receptor ligands, Journal of Enzyme Inhibition and Medicinal Chemistry 26(3), 412-421.
Lipinski C., Hopkins A., (2004) Navigating Chemical Space for Biology Andmedicine. Nature 432, 855–861.
- Abstract Viewed: 236 times
- PDF Downloaded: 219 times